Peripheral neuropathy occurs as a component of several common and many rare diseases. It is heterogenous in aetiology, diverse in pathology, and varied in severity. The term peripheral neuropathy includes symmetric polyneuropathy, single and multiple mononeuropathy, and radiculopathy. Further classification depends on a mixture of phenomenological, pathological, and genetic or other aetiological features. All of these things cause problems for epidemiologists who, without agreed definitions of what constitutes a case, find it difficult to describe patterns of occurrence of disease. Perhaps it is not very surprising that information about the descriptive epidemiology of peripheral neuropathy derived from population based studies is scarce.
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What data do exist suggest that peripheral neuropathy may be rather commoner than is usually thought. A recent study, carried out in two regions of Italy, estimated the frequency of chronic symmetric symptomatic polyneuropathy in people over the age of 55 years attending general practitioners' surgeries. Probable polyneuropathy was diagnosed if they answered positively to a screening questionnaire for neuropathic symptoms and showed signs compatible with peripheral neuropathy when examined by a neurologist.' Around 8% of people met these diagnostic criteria for polyneuropathy. The commonest condition associated with polyneuropathy was diabetes. This study was not population based; only people already attending their general practitioner were included-a group in whom chronic disease is likely to be overrepresented and who will therefore be at increased risk of neuropathy. Despite this caveat, the rate of polyneuropathy detected was surprisingly high. Two studies of prevalence, one in Bombay2 and the other in Sicily,3 also suggest that peripheral neuropathy is common in the community. Cases were identified by a door to door survey. Those who answered positively to questions about sensory or motor symptoms were examined by a neurologist. In Bombay the prevalence of peripheral neuropathy was 2-4% and the commonest diagnoses were carpal tunnel syndrome and diabetic peripheral neuropathy. In Sicily, 7% of the population responded positively to the initial screening questions. After further investigation, diabetic neuropathy was diagnosed in 0 3% but no details about the frequency of other types of neuropathy were published.
Peripheral neuropathies are a disparate group of diseases. Attempts to consider them as a whole emphasise their contribution to the burden of disease and disability in the community, but may obscure interesting epidemiological features that could lead to a better understanding of aetiology. In this review we consider the commoner forms of peripheral neuropathy separately.
Diabetic neuropathies
The neuropathic complications of diabetes mellitus include distal, symmetric, predominantly sensory neuropathy, autonomic neuropathy, asymmetric proximal neuropathy, and cranial and other mononeuropathies. Several of these neuropathic manifestations may coexist in same patient. Although the time course and prognosis of the different types of neuropathy vary, little is known about how this reflects differences in underlying pathology.
An early study of diabetic peripheral neuropathy in a population used retrospective review of case records to ascertain symptoms or signs of neuropathy. The most prevalent type is the demyelinating form, CMT1. In a study in northern Sweden, CMT1 accounted for 80% of cases whereas the axonal or neuronal form, CMT2, accounted for the remaining 20%.'9 A collaborative European study showed that about 70% of patients with CMT1 have an identifiable duplication of the gene for a 22 kDa peripheral nerve myelin protein PMP22 on the short arm of chromosome 17, at position 17pi 12." In the others, various point mutations have been found in the PMP22, PO, and connexin 32 genes. The last is on the X chromosome and accounts for X linked cases. About 10% of families with autosomal dominant CMT1 have de novo duplications, usually, but not always, arising from duplication during male meiosis. 23 The severity of CMT is variable, even within families. Hereditary neuropathy may be subclinical, mild and late in onset, or severe from an early age. Hereditary neuropathy with liability to pressure palsies is an autosomal dominant condition, being due in most symptomatic cases (84% in the European collaborative study) to deletion of the same gene which is duplicated in the autosomal dominant subtype CMT1A at 17pl 12.22 The phenotype is even more variable than in CMT1 and some cases are asymptomatic.
Amyloid neuropathy is the other common cause of hereditary neuropathy, being due to deposition of transthyretin, or less commonly other proteins, in the peripheral nerves, although it may also be an acquired disorder secondary to B cell dyscrasia and immunoglobulin light chain deposition. The nature of the mutation in the transthyretin gene determines the pattern of deposition and the presenting features of the neuropathy. The commonest mutation causes the substitution of methionine for valine at position 30 which results in a late onset, progressive, painful, Campylobacter jejuni is also the commonest identified infection preceding sporadic GBS in other countries. In large series of cases of GBS (n > 100) in the United Kingdom,3139 The Netherlands,40 and the United States,41 the frequency of serological evidence of recent Campylobacter infection has ranged from 26 to 36% of cases of GBS, far exceeding the incidence in control groups,31 39 44 There is a single report, needing confirmation, of induction of acute axonal neuropathy in chickens which had been fed or injected with Campylobacter isolated from the stool of a Chinese patient with the acute motor axonal neuropathy form of GBS. 45 There have been many single reports, and also small series of cases of GBS after therapeutic injection of ganglioside preparations.4-8 Many, but not all, of the affected patients have had antibodies to ganglioside GM1 in their serum. There was no rise in the incidence of GBS after the introduction of ganglioside treatment during ongoing epidemiological surveys of GBS in Italy. Casecontrol studies have not proved a causal connection but the circumstantial evidence is strong. 49 GBS is such a striking illness that when it occurs after an event such as an immunisation, it tends to be reported either in the medical literature or in the law courts. With the exception of vaccinia, the old fashioned rabies vaccines, which contained myelin components,50 and the 1976 United States swine influenza vaccine,5' the evidence that immunisations trigger GBS is not strong. However, disproving small increases in risk is difficult in diseases as uncommon as GBS. In two case control studies, comprising over 200 cases in south east England, the odds ratio of cases having been immunised was 1-8, not significantly increased compared with controls, but the 95% confidence intervals ranged from 0 7 to 44.52 The epidemiologically demonstrated association between swine influenza vaccine and GBS was never explained. Ongoing By contrast with GBS there is very little epidemiological information concerning CIDP (defined as an acquired idiopathic demyelinating neuropathy with a progressive phase > eight weeks). The distinction between the acute inflammatory demyelinating polyradiculoneuropathy form of GBS and CIDP may be artificial as the distribution of onset phases is unimodal, not bimodal,55 and intermediate subacute forms occur.56 It is probably an uncommon condition but the neurophysiological and nerve biopsy assessments required for its diagnosis are complex so that it is probably underdiagnosed. There are no reliable population estimates of its prevalence yet, but our own data suggest a minimum prevalence of at least 1 per 100 000. The only published information at present comes from large hospital series which suggest that the disease occurs throughout the world and at all ages. Its course is more often relapsing-remitting than progressive, and progressive cases tend to be older.57 Antecedent infections are reported less commonly than before GBS, being recalled in only 25% of 40 patients in the most recent study in which this information was specifically sought.58 Although immunisations have also been incriminated as triggering CIDP, the evidence that they either trigger CIDP or cause relapse is weak.59 HIV ASSOCIATED NEUROPATHY Various peripheral nerve syndromes have been reported in association with HIV infection including acute and chronic inflammatory demyelinating neuropathies, distal sensory neuropathy-often of a painful type-and multiple mononeuropathy. In addition, treatment with dideoxynucleosides, particularly ddC, may cause a dose related toxic neuropathy.60 Information about HIV associated neuropathy is mainly derived from case reports and follow up, often incomplete, of clinic based case series. The reported frequency of occurrence of peripheral neuropathy varies considerably, which probably reflects differences in duration of infection among cases in the different series.
A distal, symmetric, painful, predominantly sensory axonal neuropathy is the commonest peripheral nerve syndrome associated with HIV infection.6' Two large studies have shown that it is rare in the early stages of infection. In a cohort of around 800 HIV positive airforce personnel, all of whom had recently been considered fit for active duty, only 12 had symptoms or signs of neuropathy.62 This finding confirmed the results of the multicentre AIDS cohort study.63 Studies of groups of patients with more advanced disease have found higher rates.60 Among 54 HIV infected patients referred to a neurological clinic over a 15 month period, distal symmetric peripheral neuropathies were present in 38. Two thirds of these had a distinct clinical syndrome characterised by painful paraesthesiae or sensations of burning in both feet and, in the eight patients who underwent sural nerve biopsy, axonal atrophy. There was a clear temporal relation between the onset of symptoms and cytomegalovirus infection. Neuropathies in the other patients were more heterogenous. They included multiple mononeuropathy, isolated mononeuropathies, and lumbosacral polyradiculopathy.
Demyelinating inflammatory polyneuropathy has been reported to occur at the time of seroconversion but it seems to be a rare event and is usually followed by complete recovery. More recently, an epidemic of a neurological syndrome the clinical features of which were dominated by a peripheral sensorimotor neuropathy occurred in Spain as a result of the use of denatured rape seed oil that was sold as cooking oil. Neuropathological studies showed the unusual appearance of an intense inflammatory perineuritis followed by perineurial fibrosis with degeneration of myelinated axons. The oil contained high concentrations of peroxides and it was conjectured that nerve damage was caused by the action of free radicals.80
Alcohol Peripheral nerve dysfunction is common in people who chronically misuse alcohol. There has been a long debate about whether this is due to a direct toxic effect of alcohol or whether it is a result of chronic nutritional deficiency. In a recent series of 107 alcoholic patients presenting at a Spanish hospital clinic, about a quarter showed abnormalities on tests of cardiovascular autonomic reflexes and a third fulfilled electrophysiological criteria of peripheral neuropathy.81 Correlations between total lifetime dose of alcohol and sensory nerve compound action potential amplitudes were found but there was no relation to age, nutritional status, or the presence of other alcohol related diseases. Although thiamine deficiency has traditionally been thought to play a part in the pathogenesis of alcoholic neuropathy, a recent study of blood concentrations of free thiamine in chronic alcoholics showed no differences between those with and without peripheral neuropathy or between alcoholics and a control group.82
Bell's palsy Bell's palsy, a unilateral, lower motor neuron facial paralysis, is the commonest condition affecting the facial nerve. Studies of incidence have been carried out in the United States and in Japan. All relied on retrospective examination of hospital and clinic records to ascertain cases and are likely to have underestimated the frequency of mild cases that remained undiagnosed or were treated in primary care. Crude incidence rates in these studies were fairly similar: in Rochester, Minnesota, USA, annual incidence was 25 per 100 000 population; in Laredo, Texas, USA, per 100 000 in men and 32-7 per 100 000 in women; and in Ehime prefecture, Japan, 30 per 100 000 population. Rates for men and women were similar in Rochester and in the Ehime prefecture. Logistic regression analysis of the data from Rochester suggested that complete facial weakness, pain other than in or around the ear, and systemic hypertension were the most important predictors of incomplete recovery but out of 206 patients only 28 (14%) experienced incomplete recovery.
Evidence implicating local reactivation of herpes simplex virus type 1 in the aetiology of Bell's palsy comes from a recent report of a small series of patients who had decompressive surgery of the facial nerve.86 Fragments of DNA specific for herpes simplex virus were detected by Southern blot analysis in endoneurial fluid from the affected facial nerve or in tissue from biopsy of the posterior auricular muscle after amplification by polymerase chain reaction in 11 out of 14 patients. No such fragments were found in fluid or tissue from the control group which consisted of nine patients with Ramsay-Hunt syndrome and 12 patients with a mixture of other diagnoses.
Neuralgic amyotrophy A population based study of neuralgic amyotrophy in Rochester, Minnesota identified 11 cases over a period of 12 years giving an overall annual incidence of 1 6 per 100 000 population. 87 Retrospective analysis of case series and case reports have suggested various antecedent events: various infectious illnesses, immunisations, surgery, intravenous drug misuse, intravenous administration of radiological contrast medium, trauma in areas of the body remote from the brachial plexus, and childbirth. Detailed electrophysiological investigation of a small case series showed various lesions of individual peripheral nerves or their branches sometimes occurring singly and sometimes in combination. 88 These authors hypothesised that the course of these nerves, especially their location across joints, selectively exposed them to mild focal trauma and rendered them more susceptible to the disease.
Some cases of neuralgic amyotrophy are familial. The condition is apparently inherited as an autosomal dominant trait and may be associated with mildly dysmorphic facial features. In linkage studies of two large pedigrees, the gene was mapped to the distal part of the long arm of chromosome 17.89 However, the disorder is genetically, as well as clinically, distinct from mutation in the PMP22 gene associated with hereditary neuropathy with liability to pressure palsies. 90 Carpal tunnel syndrome Carpal tunnel syndrome, caused by compression of the median nerve where it passes under the transverse carpal ligament in the wrist, is a common diagnosis in neurology and rheumatology outpatient clinics but there is remarkably little information about the frequency of its occurrence in the population generally. In a population based study of its prevalence in The Netherlands, carpal tunnel syndrome had been previously diagnosed in 3-4% of women and was present, undiagnosed, in a further 5.8%.9l By contrast, in men the overall preva-lence was only 0-6%. The medical records linkage system at the Mayo clinic has been used to study the incidence of the condition. The crude annual incidence rate during the period 1961 to 1980 was 99 per 100 000. Age adjusted sex specific rates showed a female to male ratio of 3:1.92 Incidence rates increased during each sequential five year period of the study, from 88 per 100 000 to 125 per 100 000 but it was thought that this increase was more likely to reflect better recognition of the condition than a true increase in the underlying incidence. Rates increased with age in men, but in women incidence peaked in the 45 to 54 age group. suggests that treatment of carpal tunnel syndrome by surgical decompression is moderately effective in relieving pain, a study in the United States of 191 men and women of working age treated surgically found that the mean time lost from work was four months and that 8% of cases lost more than one year from work. 96 In a large cohort of women followed up in the Oxford Family Planning Association contraceptive study, carpal tunnel syndrome was associated with obesity and a history of menstrual disorders. There was also a strong and unexpected association with smoking. 
